Skip To Main Content
Contact us
|
Help
Home
About
ADR
ADR Archives
Resources
Contact
Flash e-reader
Choose a chapter:
Introduction
Kidney
Pancreas
Liver
Intestine
Heart
Lung
Deceased Organ Donation
Allocation Policies
Appendix
Table Selection
Choose an organ:
All Organs
Kidney
Pancreas
Kidney/Pancreas
Heart
Lung
Heart/Lung
Intestine
Liver
Choose a group:
Choose a characteristic:
Requires
Adobe Acrobat Reader
Table 13.6b
Immunosuppression Use for Induction by Discharge Regimen, 2005 to 2009
Recipients with Heart-Lung Transplants
Discharge Regimen (w/ or w/o Steroids Use)
All
CyA
Tac
CyA+ MMF
Tac+ MMF
CyA+ Aza
Tac+ Aza
Other
Functioning Graft with Immunosuppression Info at Discharge
1
9
9
78
14
9
5
125
% of All Regimens
0.8%
7.2%
7.2%
62.4%
11.2%
7.2%
4.0%
100.0%
Induction Drug
0.0%
11.1%
22.2%
14.1%
21.4%
0.0%
40.0%
15.2%
Atgam/NRATG/NRATS
OKT3
0.0%
11.1%
0.0%
1.3%
7.1%
0.0%
0.0%
2.4%
Thymoglobulin
0.0%
0.0%
0.0%
5.1%
0.0%
0.0%
0.0%
3.2%
Zenapax
0.0%
22.2%
11.1%
21.8%
28.6%
11.1%
80.0%
23.2%
Simulect
0.0%
11.1%
55.6%
7.7%
21.4%
44.4%
80.0%
18.4%
Campath
0.0%
11.1%
0.0%
19.2%
0.0%
0.0%
60.0%
15.2%
No Induction Drugs Recorded
100.0%
55.6%
11.1%
33.3%
21.4%
44.4%
0.0%
32.0%
Source: OPTN/SRTR Data as of October 1, 2010.
Induction drugs include any reported antilymphocyte antibodies and antibodies directed against lymphocyte receptors.
Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.
CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.